WARFARIN SODIUM - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for warfarin sodium and what is the scope of patent protection?

Warfarin sodium is the generic ingredient in five branded drugs marketed by Bristol Myers Squibb, Pharm Res Assoc, Upsher Smith Labs, Abbott, Amneal Pharms, Aurobindo Pharma Usa, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for warfarin sodium. Twenty-four suppliers are listed for this compound.

Summary for WARFARIN SODIUM

US Patents:	0
Tradenames:	5
Applicants:	15
NDAs:	21
Drug Master File Entries:	20
Finished Product Suppliers / Packagers:	24
Raw Ingredient (Bulk) Api Vendors:	79
Clinical Trials:	38
Patent Applications:	6,575
Drug Prices:	Drug price trends for WARFARIN SODIUM
Drug Sales Revenues:	Drug sales revenues for WARFARIN SODIUM
What excipients (inactive ingredients) are in WARFARIN SODIUM?	WARFARIN SODIUM excipients list
DailyMed Link:	WARFARIN SODIUM at DailyMed

See drug prices for WARFARIN SODIUM

Drug Sales Revenue Trends for WARFARIN SODIUM

See drug sales revenues for WARFARIN SODIUM

Recent Clinical Trials for WARFARIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Amgen	Early Phase 1
Boehringer Ingelheim	N/A
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Phase 1

See all WARFARIN SODIUM clinical trials

Pharmacology for WARFARIN SODIUM

Drug Class	Vitamin K Antagonist
Mechanism of Action	Vitamin K Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for WARFARIN SODIUM

B01AA	Vitamin K antagonists
B01A	ANTITHROMBOTIC AGENTS
B01	ANTITHROMBOTIC AGENTS
B	Blood and blood forming organs

US Patents and Regulatory Information for WARFARIN SODIUM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040663-002	May 30, 2006	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal Pharms	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	202202-008	Mar 4, 2013	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Invagen Pharms	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	090935-005	May 25, 2011	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.